News
All NewsFDA UpdatesPress Releases
Media
All VideosDigital DetailIndependent CornerInsightsInterviewsMEDcastMedical World NewsMicrositesPeer ExchangePerfect ConsultPodcastsPractice PearlsSponsored WebcastStudent VoicesWebinars/Webcasts
Conferences
Conference CoverageConference Listing
Publications
Pharmacy TimesPharmacy Practice in Focus: OncologyPharmacy Practice in Focus: Health SystemsPharmacy CareersAll PublicationsAbout the PublicationsAuthor SubmissionSubmit to Pharmacy Practice in Focus: OncologySubmit to Pharmacy Practice in Focus: Health SystemsBecome a Peer ReviewerSupplements & Featured Publications
More
Events
Upcoming EventsUpcoming Webinars
CE
Resources
Clinical ForumAmerican Heart MonthEducated PatientInformation for the PharmacistInteractive ToolsPartnersSponsoredWhiteboards

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CE
  • Resources
  • Subscribe
  • 503B Compounding Pharmacy
  • ADHD
  • Allergy
  • Alzheimer Disease
  • Anxiety
  • Asthma
  • Atopic Dermatitis
  • Biosimilars
  • Bipolar Disorder
  • Brain Health
  • Breast Cancer
  • C. difficile
  • COPD
  • COVID-19
  • Cardiovascular Health
  • Cervical Cancer
  • Cholangiocarcinoma
  • Cholesterol
  • Chronic Kidney Disease
  • Chronic Lymphocytic Leukemia
  • Classical Hematology
  • Colorectal Cancer
  • Continuous Glucose Monitoring
  • Cough and Cold
  • Depression
  • Dermatology
  • Diabetes
  • Digestive Health
  • Dry Eye Disease
  • Endometrial Cancer
  • Epilepsy
  • Eye Care
  • Flu
  • Future of Pharmacy
  • Gastrointestinal Cancer
  • Gastrointestinal Health
  • Gout
  • HER2 Breast Cancer
  • HIV
  • Heart Failure
  • Hematology
  • Hepatitis/MASH
  • Immunization
  • Immuno-oncology
  • Immunoglobulins
  • Infectious Disease
  • Lung Cancer
  • Lymphoma
  • Macular Degeneration
  • Mental Health
  • Migraine
  • Movement Disorders
  • Multiple Myeloma
  • Multiple Sclerosis
  • Myelofibrosis
  • Neurology
  • Neutropenia
  • Osteoporosis
  • Ovarian Cancer
  • Pain Management
  • Parkinson Disease
  • Pediatrics
  • Pneumococcal
  • PrEP
  • Prostate Cancer
  • Psoriasis
  • Psoriatic Arthritis
  • Psychedelics
  • Reproductive Health
  • Respiratory Syncytial Virus
  • Rheumatoid Arthritis
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep
  • Travel Vaccines
  • Veterinary Pharmacy
  • Vitamins and Supplements
  • Weight Management
  • Women's Health
Spotlight -
Community/Retail|
Hospital|
Oncology|
Pharmacy Technician|
Student
Advertisement

Phillip Hansten, PharmD

Advertisement

Articles by Phillip Hansten, PharmD

Reducing Drug Interaction Alerts: Not So Easy

ByJohn R. Horn, PharmD, FCCP,Phillip Hansten, PharmD
June 1st 2007

Potential Drug Interactions in Smokers and Quitters

ByJohn R. Horn, PharmD, FCCP,Phillip Hansten, PharmD
May 1st 2007

The Parachute Principle of Drug Interactions

ByJohn R. Horn, PharmD, FCCP,Phillip Hansten, PharmD
April 1st 2007

Interactive Properties of Tizanidine (Zanaflex)

ByJohn R. Horn, PharmD, FCCP,Phillip Hansten, PharmD
January 1st 2006
Advertisement

Latest Updated Articles

  • Reducing Drug Interaction Alerts: Not So Easy
    Reducing Drug Interaction Alerts: Not So Easy

    Published: June 1st 2007 | Updated:

  • Potential Drug Interactions in Smokers and Quitters
    Potential Drug Interactions in Smokers and Quitters

    Published: May 1st 2007 | Updated:

  • The Parachute Principle of Drug Interactions
    The Parachute Principle of Drug Interactions

    Published: April 1st 2007 | Updated:

  • Interactive Properties of Tizanidine (Zanaflex)
    Interactive Properties of Tizanidine (Zanaflex)

    Published: January 1st 2006 | Updated:



Advertisement
Advertisement

Trending on Pharmacy Times

1

Positive Phase 2a Trial Supports FDA Clearance of StemCyte’s HPC Therapy for Long COVID Patients

2

What Pharmacists Should Know About Most Favored Nation as Drug Prices Continue to Rise

3

From Underdiagnosed to Under Control: Plozasiran and Pharmacists’ Role in FCS

4

A Defining Moment for Health System Pharmacy: Advancing Competency, Policy, and Patient Need in 2026

5

Centanafadine for Treatment of ADHD in Children, Adolescents, and Adults Accepted By FDA for Priority Review

  • About Us
  • Clinical Forums
  • Advertise
  • Contact Us
  • Editorial Staff
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Contemporary Clinic
  • OTC Guide
  • Pharmacy Times
  • Pharmacist Mom's Group
  • Pharmacist Mom's Group
Pharmacy Times
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us